SUE ALEXANDER was thinking about St. John's Wort and keyed into 
cyberspace:
SA>MARK PROBERT wrote in a message to ALL:
SA>MP> NIH Studies St. John's Wort
SA>   (snip)
SA>MP> The three-year study will involve 336 patients with major
SA>MP> depression, of  whom one-third will receive a 900 milligram (mg)
SA>MP> daily dose of St.  John's wort, one-third will receive a placebo,
SA>MP> and one-third will  receive a selective serotonin reuptake
SA>MP> inhibitor. 
SA>     Are you familiar with the use of St John's wort?  I was
SA>wondering if this is an appropriate dose for treatment purposes and
SA>if there are any interactions with drugs or food.
The purpose of the study is to determine safety, efficacy, dosage and 
interactions. 
I would never presume to know such things before they are empirically 
tested.
               The Few. The Proud. The Chosen.
                     markprobe@aol.com
---
 * CMPQwk #1.4 * UNREGISTERED EVALUATION COPY
---------------